- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
8
Mid-Large Cap Stocks
8 companies
BioGaia
Market Cap: SEK 10.6b
A healthcare company, provides probiotic products worldwide.
BIOG B
SEK 105.50
7D
4.6%
1Y
-20.3%
Biotage
Market Cap: SEK 11.3b
Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.
BIOT
SEK 141.60
7D
0.1%
1Y
-21.1%
Camurus
Market Cap: SEK 36.4b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 543.50
7D
-17.8%
1Y
-2.9%
AddLife
Market Cap: SEK 22.8b
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 187.00
7D
-0.6%
1Y
63.9%
Bonesupport Holding
Market Cap: SEK 18.4b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 284.60
7D
-1.9%
1Y
16.5%
Vitrolife
Market Cap: SEK 21.1b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 155.40
7D
-0.6%
1Y
-18.4%
BioArctic
Market Cap: SEK 15.6b
Develops biological drugs for patients with disorders of the central nervous system in Sweden.
BIOA B
SEK 175.30
7D
-2.5%
1Y
-24.4%
Swedish Orphan Biovitrum
Market Cap: SEK 102.1b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 306.80
7D
3.0%
1Y
8.6%